Your Messages Inbox
Your Article Summary
See Latest ArticlesRecession-proof companies Part I: Galapagos
PharmExec, 08/05/09
Onno van de Stolpe has led biotechnology company Galapagos since it was founded as a joint venture between Crucell and Tibotec in 1999. Launching amidst the boom in genomics research, the company has pursued a successful expansion policy, acquiring drug discovery company BioFocus DPI in 2005. Here, Onno talks to Pharma Exec Europe about the secret of Galapagos's success, and why he is confident the company can ride out the economic downturn with no adverse effects.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
b3c newswire, 12/07/09
Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN at 51st ASH Annual Meeting
Allos Therapeutics, 12/07/09
Nplate Data From MDS Studies Presented at ASH
Amgen, 12/07/09
Article Search
Sponsor